Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Revenues Increase 12 Percent in Q2

NEW YORK, July 15 (GenomeWeb News) - GE Healthcare's revenues during the second quarter of 2005 increased 12 percent year over year, to $3.8 billion, GE reported today.


The business unit, which incorporated Amersham Biosciences in April of last year, contributed 9 percent to GE's overall quarterly revenues of $41.6 billion, similar to the same period in 2004. GE's total revenues were up 13 percent over last year's $36.8 billion during the second quarter.


Orders for the healthcare business unit grew 11 percent over the second quarter of 2004, to $3.9 billion, $2.5 billion of which came from equipment orders.


Healthcare had $672 million in profits, up 15 percent from $584 million during the same period last year.


GE's total earnings amounted to $4.6 billion, up 24 percent from $3.8 billion in the second quarter of last year. Earnings per share were $.44, up 22 percent over last year's $.36 during the same period.


As of June 30, GE had $146 billion in cash and marketable securities.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.